We further checked the gene expression in primary tumor versus normal tissue for genes JAK2, PRDM16, LRP1B, NIN, and NKX2-1 with variants repeatedly enriched in variant-based analysis, and, FANCE, enriched in gene-based burden testing, using the TCGA database (Supplementary Figure S5). This evidence concerns the gene JAK2 and neoplasm.